TEAD1 and glioma: Survival analysis showed that patients with high methylation levels of TEAD1 had better prognoses in GBM, LUSC, and skin cutaneous melanoma (SKCM), while the opposite was true in KIRC, lower grade glioma (LGG), and uveal melanoma (UVM) (Figures 3C–H).